1,2-dichloro-1,2,3,3,4,4-hexafluorocyclobutane has been researched along with Seizures in 1 studies
*Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eger, EI; Flood, P; Gong, D; Raines, DE; Xing, Y | 1 |
1 other study(ies) available for 1,2-dichloro-1,2,3,3,4,4-hexafluorocyclobutane and Seizures
| Article | Year |
|---|---|
Acetylcholine receptors and thresholds for convulsions from flurothyl and 1,2-dichlorohexafluorocyclobutane.
Topics: Animals; Chlorofluorocarbons; Cyclobutanes; Flurothyl; GABA-A Receptor Antagonists; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Nicotinic; Seizures | 2002 |